期刊文献+

克罗恩病肛瘘保留括约肌手术研究进展

原文传递
导出
摘要 克罗恩病(Crohn's disease,CD)是累及全消化道的慢性非特异性炎性疾病.肛瘘是肛周CD的主要表现形式,发病率为13%~27%[1].70%~80%的CD肛瘘为复杂性肛瘘,临床特征多为瘘管上皮化程度低、内口位于直肠、同时或短期内出现多根瘘管、累及高位肛门括约肌[1].手术治疗CD肛瘘肛门失禁风险大,首选保留括约肌术式.我们对CD肛瘘保留括约肌手术近期研究进行综述,期望为临床提高CD肛瘘外科治疗提供新思路.
出处 《中华炎性肠病杂志(中英文)》 2018年第2期131-134,共4页 Chinese Journal of Inflammatory Bowel Diseases
基金 苏州市产业技术创新专项项目(SYSD2016137) 苏州市“科教兴卫”青年科技项目(KJXW2016037).
  • 相关文献

参考文献2

二级参考文献38

  • 1Ardizzone S, Porto GB. Perianal Crohn's disease: overview. Dig Liver Dis, 2007,39:957-958. 被引量:1
  • 2Chung W, Kazemi P, Ko D, et al. Anal fistula plug and fibrin glue versus conventional treatment in repair of complex anal fistulas. Am J Surg, 2009,197 : 604-608. 被引量:1
  • 3Sands BE, Anderson FI-I, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med, 2004,350 : 876-885. 被引量:1
  • 4Orlando A, Colombo E, Kohn A, et al. Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. Dig Liver Dis, 2005,37:577-583. 被引量:1
  • 5D' Haens GR, Panaccione R, Higgins PD, et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol, 2011,106:199-212. 被引量:1
  • 6Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis, 2003,9 : 98-103. 被引量:1
  • 7Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg, 2010,53:299-304. 被引量:1
  • 8Gaertner WB, Decanini A, Mellgren A, et al. Does infliximab infusion impact results of operative treatment for Crohn' s perianal fistulas? Dis Colon Rectum, 2007,50:1754-1760. 被引量:1
  • 9Topstad DR, Panaccione R, Heine JA, et al. Combined seton placement, infiiximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum, 2003,46 : 577-583. 被引量:1
  • 10Clark M, Colombel JF, Feagan BC, et al. American gastroenterologieal association consensus development conference of the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology, 2007,133 : 312- 339. 被引量:1

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部